SEARCH

SEARCH BY CITATION

References

  • 1
    Segikuchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic prognostic and therapeutic considerations. Cardiovasc Drugs Ther 1996; 10: 495510.
  • 2
    Kim JS, Judson MA, Donnino R, Gold M, Cooper LT, Prystowsky EN. Cardiac sarcoidosis. Am Heart J 2009; 157: 921.
  • 3
    Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006; 92: 2828.
  • 4
    Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005; 96: 27682.
  • 5
    Fleming HA, Bailey SM. The prognosis of sarcoid heart disease in the United Kingdom. Ann N Y Acad Sci 1986; 46: 54350.
  • 6
    Yazaki Y, Isobe M, Hiroe M et al. Prognostic determinants in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 100610.
  • 7
    Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005; 159: 45963.
  • 8
    Jpn Ministry Health Welfare. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord 2007; 27: 89102.
  • 9
    Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy Findings in Patients with Sarcoidosis Dying Suddenly from Cardiac Sarcoidosis Versus dying Suddenly from Other Causes. Am J Cardiol 2009; 104: 5717.
  • 10
    Ratner SJ, Fenoglio JJ, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986; 90: 52833.
  • 11
    Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299302.
  • 12
    Patel MR, Cawley PJ, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 196977.
  • 13
    Ishimaru S, Tsujino I, Takei T et al. Focal uptake on 1f-F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005; 26: 153843.
  • 14
    Yamagishi H, Shirai N, Takagi M et al. Identification of Cardiac Sarcoidosis with 13N-NH3/18F-FDG PET. J Nucl Med 2003; 44: 10306.
  • 15
    Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18F-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009; 16: 80110.
  • 16
    Felker GM, Thompson RE, Hare JM. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 107784.
  • 17
    Hiraga H, Yuwa K, Hiroe M. Guideline for the diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease. Jpn Ministry Health Welfare 1993; 234.
  • 18
    Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N. Usefulness of fasting 18-F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004; 45: 198998.
  • 19
    Ohira H, Tsujino I, Ishimaru S et al. Myocardial imaging with 18-F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008; 35: 93341.
  • 20
    Ichinose A, Otani H, Oikawa M et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. Am J Roentgenol 2008; 191: 8629.
  • 21
    Matoh F, Satoh H, Shiraki K et al. The usefulness of delayed enhacement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol 2008; 51: 17988.
  • 22
    Banba K, Fukushima K, Nakamura K et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4: 12929.
  • 23
    Otsuka K, Terasaki F, Eishi Y et al. Cardiac sarcoidosis underlies idiopathic dilated cardiomyopathy. Importance of mediastinal lymphadenopathy in differential diagnosis. Circ J 2007; 71: 193741.
  • 24
    Uusimaa P, Ylitalo K, Anttonen O et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008; 10: 7606.
  • 25
    Alam M, Virani SS, Simpson SB, Wilson JM. Cardiac sarcoidosis. A Clinical entity uncommonly recognized. Tex Heart Inst J 2009; 36: 5013.